dr. oh on a biomarker development trial in mcrpc
Published 10 years ago • 80 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:34
dr. william k. oh discusses a biomarker development trial of satraplatin in patients with mcrpc
-
1:40
dr. galsky discusses a biomarker development trial for satraplatin in mcrpc
-
3:33
prophecy trial: ar-v7 ctcs as a biomarker in mcrpc
-
1:54
dr. orr on ongoing biomarker research in ovarian cancer
-
1:11
dr. oh on validating a whole-blood rna prognostic signature in mcrpc
-
46:53
metastatic prostate cancer to bone – a cancer care seminar
-
11:36
what does blood in the urine mean? | prostate expert, mark scholz, md
-
6:51
urine biomarkers for diagnosis and follow-up/recurrence
-
0:38
copy of dr. orr on ongoing biomarker research in ovarian cancer
-
2:48
assessing parp inhibition and brca1/2 as a prognostic biomarker in mcrpc
-
58:31
audio version uronurse episode 106: new immunotherapy approaches for bladder cancer
-
1:26
dr. armstrong on ar-v7 as a biomarker of response to taxane chemotherapy in mcrpc
-
1:37
olaparib plus abiraterone for mcrpc: are biomarkers necessary?
-
8:53
prognostic biomarkers to guide treatment of mcrpc
-
1:02
dr. oh on choosing ar-targeted therapy versus chemotherapy in mhspc
-
1:56
dr. oh on targeted treatment in metastatic castration-resistant prostate cancer
-
1:36
dr. oh on results of chemotherapy versus arta in prostate cancer
-
2:10
dr. stein on trials investigating biomarkers in prostate cancer
-
1:29
dr. oh on recognizing symptom burden in advanced prostate cancer
-
1:37
recent advances in mhspc: 177lu-psma-617, propel and biomarker-directed strategies
-
1:15
dr. oh on the hormone-sensitive setting in prostate cancer
-
7:10
strategies for using biomarkers in prostate cancer